Seyed Kianoosh Hosseini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Seyed Kianoosh Hosseini has a total of 143 co-authors. Here are the top co-authors by number of shared publications:
Ahmad Sharafi
5 shared publicationsMohammad Alidoosti
Department of Interventional Cardiology, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
5 shared publicationsEbrahim Nematipour
4 shared publicationsMojtaba Salarifar
4 shared publicationsSeyed Ebrahim Kassaian
4 shared publicationsYounes Nozari
Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
4 shared publications
Latest Publications
- 15 August 2026
- Published by Maad Rayan Publishing Company in Journal Of Research In Health Sciences
- Vol. 26 (3) , e00692
A Predictive Model for Post-Percutaneous Coronary Intervention Readmission: Insights from Machine Learning on Clinical Risk Factors
Introduction: Unplanned one-year readmission after percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) poses serious clinical and economic challenges. This study developed and validated a random forest (RF) model to predict one-year all-cause unplanned readmission in STEMI-PCI patients and identify key risk factors. Study Design: A single-center retrospective cohort study. Methods: This single-center retrospective cohort study was conducted at Farshchian Heart Hospital from September 2021 to September 2024. Overall, 1,836 STEMI patients undergoing primary PCI were analyzed to predict 365-day unplanned readmission. The primary outcome was 365-day unplanned readmission (binary: readmitted or not). A RF classifier was developed on an 80/20 training-test split, optimized through repeated cross-validation with SMOTE for class imbalance. A SMOTE-RF model was also employed to mitigate the significant class imbalance inherent in the 17.6% readmission rate. Finally, key predictors were identified using mean decrease in Gini impurity. Results: Operating at an optimized threshold, the RF model demonstrated moderate discriminative ability (AUC: 0.765) with a sensitivity of 62.5% and specificity of 78.5%. Moreover, the RF model outperformed logistic regression in terms of AUC (0.695 vs. 0.765) and specificity (78.5% vs. 52%), although logistic regression achieved higher sensitivity (78.5% vs. 62.5%). Multivessel disease, smoking, length of stay, hypertension, ejection fraction, and age were key predictors of readmission identified by the RF. Conclusion: The RF model exhibited acceptable predictive performance for one-year hospital readmission, enabling clinically interpretable risk stratification and identifying key clinical risk factors to inform tailored post-discharge care. However, external validation is required to confirm its generalizability and clinical applicability.
- 15 August 2026
- Published by Maad Rayan Publishing Company in Journal Of Research In Health Sciences
- Vol. 26 (3) , e00692
A Predictive Model for Post-Percutaneous Coronary Intervention Readmission: Insights from Machine Learning on Clinical Risk Factors
Introduction: Unplanned one-year readmission after percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) poses serious clinical and economic challenges. This study developed and validated a random forest (RF) model to predict one-year all-cause unplanned readmission in STEMI-PCI patients and identify key risk factors. Study Design: A single-center retrospective cohort study. Methods: This single-center retrospective cohort study was conducted at Farshchian Heart Hospital from September 2021 to September 2024. Overall, 1,836 STEMI patients undergoing primary PCI were analyzed to predict 365-day unplanned readmission. The primary outcome was 365-day unplanned readmission (binary: readmitted or not). A RF classifier was developed on an 80/20 training-test split, optimized through repeated cross-validation with SMOTE for class imbalance. A SMOTE-RF model was also employed to mitigate the significant class imbalance inherent in the 17.6% readmission rate. Finally, key predictors were identified using mean decrease in Gini impurity. Results: Operating at an optimized threshold, the RF model demonstrated moderate discriminative ability (AUC: 0.765) with a sensitivity of 62.5% and specificity of 78.5%. Moreover, the RF model outperformed logistic regression in terms of AUC (0.695 vs. 0.765) and specificity (78.5% vs. 52%), although logistic regression achieved higher sensitivity (78.5% vs. 62.5%). Multivessel disease, smoking, length of stay, hypertension, ejection fraction, and age were key predictors of readmission identified by the RF. Conclusion: The RF model exhibited acceptable predictive performance for one-year hospital readmission, enabling clinically interpretable risk stratification and identifying key clinical risk factors to inform tailored post-discharge care. However, external validation is required to confirm its generalizability and clinical applicability.
- Open Access
- 19 June 2026
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 20
Combined oral contraceptive use as a cause of acute myocardial infarction in a young woman without traditional risk factors: a case report
Combined oral contraceptives are widely used and generally considered safe. However, they have been associated with arterial thrombosis, including myocardial infarction, particularly in women with cardiovascular risk factors. This case adds to the limited literature highlighting the potential for combined oral contraceptive-induced myocardial infarction in individuals without traditional cardiovascular risk factors. A 28-year-old non-smoking Iranian woman with no significant medical history presented with 11 h of typical anginal chest pain radiating to the left arm and interscapular area. Electrocardiography revealed ST-segment elevations in leads V2-V5, and cardiac biomarkers confirmed myocardial infarction. She had been taking a second-generation combined oral contraceptive containing 150 µg levonorgestrel and 30 µg ethinyl estradiol for 13 years. Emergent coronary angiography demonstrated a thrombotic occlusion in the mid-left anterior descending artery without evidence of underlying atherosclerosis. Successful reperfusion was achieved via balloon angioplasty without stenting. The patient remained stable, was discharged on optimal medical therapy, and advised to discontinue combined oral contraceptives. At 3-month follow-up, cardiac Computed Tomography Angiography revealed a patent left anterior descending artery with no residual stenosis, and echocardiography showed improved systolic function. This case underscores the potential for thrombotic myocardial infarction in young women using combined oral contraceptives, even in the absence of conventional risk factors. It highlights the importance of considering hormonal contraceptive history in the diagnostic workup of acute coronary syndromes in young females. In addition, it demonstrates that Balloon angioplasty without stent placement may be effective in selected cases of non-atherosclerotic thrombotic occlusion.
- 19 June 2026
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 20
Open AccessCombined oral contraceptive use as a cause of acute myocardial infarction in a young woman without traditional risk factors: a case report
Combined oral contraceptives are widely used and generally considered safe. However, they have been associated with arterial thrombosis, including myocardial infarction, particularly in women with cardiovascular risk factors. This case adds to the limited literature highlighting the potential for combined oral contraceptive-induced myocardial infarction in individuals without traditional cardiovascular risk factors. A 28-year-old non-smoking Iranian woman with no significant medical history presented with 11 h of typical anginal chest pain radiating to the left arm and interscapular area. Electrocardiography revealed ST-segment elevations in leads V2-V5, and cardiac biomarkers confirmed myocardial infarction. She had been taking a second-generation combined oral contraceptive containing 150 µg levonorgestrel and 30 µg ethinyl estradiol for 13 years. Emergent coronary angiography demonstrated a thrombotic occlusion in the mid-left anterior descending artery without evidence of underlying atherosclerosis. Successful reperfusion was achieved via balloon angioplasty without stenting. The patient remained stable, was discharged on optimal medical therapy, and advised to discontinue combined oral contraceptives. At 3-month follow-up, cardiac Computed Tomography Angiography revealed a patent left anterior descending artery with no residual stenosis, and echocardiography showed improved systolic function. This case underscores the potential for thrombotic myocardial infarction in young women using combined oral contraceptives, even in the absence of conventional risk factors. It highlights the importance of considering hormonal contraceptive history in the diagnostic workup of acute coronary syndromes in young females. In addition, it demonstrates that Balloon angioplasty without stent placement may be effective in selected cases of non-atherosclerotic thrombotic occlusion.
- Open Access
- 16 June 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Temporal changes of oxidative stress and ferroptosis-associated biomarkers in STEMI patients undergoing primary PCI and their correlation with myocardial reperfusion injury
Myocardial ischemia-reperfusion injury in ST-elevation myocardial infarction (STEMI) involves complex mechanisms, including oxidative stress and ferroptosis, but the timing and relationship of these processes with cardiac injury markers remain unclear. This study investigated how oxidative stress and ferroptosis-associated biomarkers change over time and their correlations with cardiac injury markers in STEMI patients undergoing primary percutaneous coronary intervention (PCI). A prospective cohort of 25 STEMI patients undergoing primary PCI was studied. Serum levels of cardiac injury biomarkers (Troponin I, CK-MB) and oxidative stress/ferroptosis markers (superoxide dismutase [SOD], total antioxidant capacity [TAC], glutathione peroxidase [GPx], lipid peroxidation products [LPO], serum iron, and ferritin) were measured at pre-PCI, and at 6, 12, 24, and 48 h post-PCI. Temporal trends and Pearson correlations between these biomarkers were analyzed. Markers of oxidative stress and ferroptosis-associated biomarkers demonstrated distinct time-dependent patterns post-reperfusion: SOD and TAC peaked early (6-12 h), while GPx initially decreased. LPO levels peaked at 6 h. Serum iron transiently declined, and ferritin showed a temporary increase at 6-12 h. Activities of antioxidant enzymes (SOD, GPx, TAC) showed inverse correlations with peak and cumulative cardiac injury markers in this pilot cohort, whereas higher LPO and iron showed positive correlations with greater myocardial damage observed here. CK-MB associations were stronger than those with Troponin I in this pilot cohort. In this pilot cohort, oxidative stress and ferroptosis-associated biomarkers showed rapid early changes after reperfusion in STEMI patients undergoing primary PCI, correlating with myocardial injury extent (stronger correlations with CK-MB than troponin I). These findings suggest early oxidative stress and iron dysregulation as potential therapeutic targets for reperfusion injury, warranting confirmation in larger studies.
- 16 June 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Open AccessTemporal changes of oxidative stress and ferroptosis-associated biomarkers in STEMI patients undergoing primary PCI and their correlation with myocardial reperfusion injury
Myocardial ischemia-reperfusion injury in ST-elevation myocardial infarction (STEMI) involves complex mechanisms, including oxidative stress and ferroptosis, but the timing and relationship of these processes with cardiac injury markers remain unclear. This study investigated how oxidative stress and ferroptosis-associated biomarkers change over time and their correlations with cardiac injury markers in STEMI patients undergoing primary percutaneous coronary intervention (PCI). A prospective cohort of 25 STEMI patients undergoing primary PCI was studied. Serum levels of cardiac injury biomarkers (Troponin I, CK-MB) and oxidative stress/ferroptosis markers (superoxide dismutase [SOD], total antioxidant capacity [TAC], glutathione peroxidase [GPx], lipid peroxidation products [LPO], serum iron, and ferritin) were measured at pre-PCI, and at 6, 12, 24, and 48 h post-PCI. Temporal trends and Pearson correlations between these biomarkers were analyzed. Markers of oxidative stress and ferroptosis-associated biomarkers demonstrated distinct time-dependent patterns post-reperfusion: SOD and TAC peaked early (6-12 h), while GPx initially decreased. LPO levels peaked at 6 h. Serum iron transiently declined, and ferritin showed a temporary increase at 6-12 h. Activities of antioxidant enzymes (SOD, GPx, TAC) showed inverse correlations with peak and cumulative cardiac injury markers in this pilot cohort, whereas higher LPO and iron showed positive correlations with greater myocardial damage observed here. CK-MB associations were stronger than those with Troponin I in this pilot cohort. In this pilot cohort, oxidative stress and ferroptosis-associated biomarkers showed rapid early changes after reperfusion in STEMI patients undergoing primary PCI, correlating with myocardial injury extent (stronger correlations with CK-MB than troponin I). These findings suggest early oxidative stress and iron dysregulation as potential therapeutic targets for reperfusion injury, warranting confirmation in larger studies.
- 1 November 2024
- Published by Bentham Science Publishers Ltd. in Current Cardiology Reviews
- Vol. 20 (6) , 1-12
CT-derived Fractional Flow Reserve: How, When, and Where to use this Novel Cardiac Imaging Tool
: Fractional flow reserve computed tomography (FFRCT) is a novel imaging modality. It utilizes computational fluid dynamics analysis of coronary blood flow obtained from CCTA images to estimate the decrease in pressure across coronary stenosis during the maximum hyperemia. : The FFRCT can serve as a valuable tool in the assessment of coronary artery disease (CAD). This non-invasive option can be used as an alternative to the invasive fractional Flow Reserve (FFR) evaluation, which is presently considered the gold standard for evaluating the physiological significance of coronary stenoses. It can help in several clinical situations, including Assessment of Acute and stable chest pain, virtual planning for coronary stenting, and treatment decision-making. : Although FFRCT has demonstrated potential clinical applications as a non-invasive imaging technique, it is also crucial to acknowledge its limitations in clinical practice. As a result, it is imperative to meticulously evaluate the advantages and drawbacks of FFRCT individually and contemplate its application in combination with other diagnostic examinations and clinical data.
- 1 November 2024
- Published by Bentham Science Publishers Ltd. in Current Cardiology Reviews
- Vol. 20 (6) , 1-12
CT-derived Fractional Flow Reserve: How, When, and Where to use this Novel Cardiac Imaging Tool
: Fractional flow reserve computed tomography (FFRCT) is a novel imaging modality. It utilizes computational fluid dynamics analysis of coronary blood flow obtained from CCTA images to estimate the decrease in pressure across coronary stenosis during the maximum hyperemia. : The FFRCT can serve as a valuable tool in the assessment of coronary artery disease (CAD). This non-invasive option can be used as an alternative to the invasive fractional Flow Reserve (FFR) evaluation, which is presently considered the gold standard for evaluating the physiological significance of coronary stenoses. It can help in several clinical situations, including Assessment of Acute and stable chest pain, virtual planning for coronary stenting, and treatment decision-making. : Although FFRCT has demonstrated potential clinical applications as a non-invasive imaging technique, it is also crucial to acknowledge its limitations in clinical practice. As a result, it is imperative to meticulously evaluate the advantages and drawbacks of FFRCT individually and contemplate its application in combination with other diagnostic examinations and clinical data.
- Open Access
- 1 August 2024
- Published by Scifiniti Publishing
- Vol. 1 (1) , 1-10
Evaluation of IL 12 Gene Expression and Serum Levels of OxPL / apoB in Patients with Coronary Artery Disease
Background Atherosclerotic lesions are formed as a result of low-density lipoprotein (LDL) accumulation, which is produced by oxidizing enzymes and oxidized phospholipids (OxPL). Phospholipid oxide causes inflammation-inducing activation genes and hyper-inflammation in addition to the initiation of inflammation and expression of Th1 cytokines. Interleukin 12 (IL-12) is one of the most significant stimulants of inflammation and immune responses, among the Th1cytokines. Therefore, it may play a significant role in contributing to atherosclerosis. The quantitative expression of IL-12 mRNA, along with serum OxPL levels, has been analyzed in patients with coronary artery disease (CAD). Methods: Coronary angiography patients, aged 45 to 65 years and referred with chest pain, were examined. The patients were classified into normal coronary arteries (N = 38) and severe three-vessel involvement coronary arteries (N = 41). Molecular testing was performed using real-time PCR. Also, an ELISA test was used to check the OxPl level. Results Expression of IL12 in Individuals with coronary artery disease was increased but was not statistically significant.
- 1 August 2024
- Published by Scifiniti Publishing
- Vol. 1 (1) , 1-10
Open AccessEvaluation of IL 12 Gene Expression and Serum Levels of OxPL / apoB in Patients with Coronary Artery Disease
Background Atherosclerotic lesions are formed as a result of low-density lipoprotein (LDL) accumulation, which is produced by oxidizing enzymes and oxidized phospholipids (OxPL). Phospholipid oxide causes inflammation-inducing activation genes and hyper-inflammation in addition to the initiation of inflammation and expression of Th1 cytokines. Interleukin 12 (IL-12) is one of the most significant stimulants of inflammation and immune responses, among the Th1cytokines. Therefore, it may play a significant role in contributing to atherosclerosis. The quantitative expression of IL-12 mRNA, along with serum OxPL levels, has been analyzed in patients with coronary artery disease (CAD). Methods: Coronary angiography patients, aged 45 to 65 years and referred with chest pain, were examined. The patients were classified into normal coronary arteries (N = 38) and severe three-vessel involvement coronary arteries (N = 41). Molecular testing was performed using real-time PCR. Also, an ELISA test was used to check the OxPl level. Results Expression of IL12 in Individuals with coronary artery disease was increased but was not statistically significant.
- Open Access
- 1 August 2024
- Published by Scifiniti Publishing
- Vol. 1 (1) , 1-10
Investigation of TLR4, TLR6, TLR7, and CD36 Expression on T lymphocytes in Coronary Artery Disease
Background: Coronary artery disease (CAD) is among the significant causes of death globally, caused by fatty deposits in blood vessel walls. Increasing evidence indicates that toll-like receptors (TLRs) are pivotal to atherosclerosis progression. The function of CD36 as a glycoprotein in atherosclerosis was also suggested. This study aimed to investigate the levels of TLR4, TLR6, and TLR7, as well as CD36 cell surface markers in CAD. Methods: This study included 64 patients undergoing angiography to determine whether atherosclerosis was present. The patients were categorized into two groups. The three main coronary arteries are all stenosed at over 50% in patients with CAD+ (n = 22) as cases and CAD− (n = 42) with smooth angiography as controls. Each patient’s syntax score (SS) and Gensini (vessel score) were calculated. The TLR-4, TLR-6, TLR-7, and CD36 expression were measured using Flow cytometry. Results: TLR4 and TLR6 showed a significant link with the Gensini score in the subject group. In addition, TLR7 had an association with Syntax scoring in this study. Conclusions: The findings illustrated the association between TLR4, TLR6, and TLR7 cell surface markers with Gensini and Syntax scoring in individuals with coronary artery disease.
- 1 August 2024
- Published by Scifiniti Publishing
- Vol. 1 (1) , 1-10
Open AccessInvestigation of TLR4, TLR6, TLR7, and CD36 Expression on T lymphocytes in Coronary Artery Disease
Background: Coronary artery disease (CAD) is among the significant causes of death globally, caused by fatty deposits in blood vessel walls. Increasing evidence indicates that toll-like receptors (TLRs) are pivotal to atherosclerosis progression. The function of CD36 as a glycoprotein in atherosclerosis was also suggested. This study aimed to investigate the levels of TLR4, TLR6, and TLR7, as well as CD36 cell surface markers in CAD. Methods: This study included 64 patients undergoing angiography to determine whether atherosclerosis was present. The patients were categorized into two groups. The three main coronary arteries are all stenosed at over 50% in patients with CAD+ (n = 22) as cases and CAD− (n = 42) with smooth angiography as controls. Each patient’s syntax score (SS) and Gensini (vessel score) were calculated. The TLR-4, TLR-6, TLR-7, and CD36 expression were measured using Flow cytometry. Results: TLR4 and TLR6 showed a significant link with the Gensini score in the subject group. In addition, TLR7 had an association with Syntax scoring in this study. Conclusions: The findings illustrated the association between TLR4, TLR6, and TLR7 cell surface markers with Gensini and Syntax scoring in individuals with coronary artery disease.
- Open Access
- 24 February 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-10
Designing and psychometric assessment of the moral intelligence scale for healthcare professionals
The moral intelligence of healthcare professionals in the cardiac operating room is one of the most important aspects of professional competence. However, moral intelligence is an abstract and multidimensional concept that needs to be clarified and described based on organizational culture and environment. Therefore, there is a need to design a specific scale for measuring the moral intelligence of healthcare professionals in the cardiac operating room. This study aims to design and assess the psychometric properties of a moral intelligence scale for healthcare professionals in the cardiac operating room. The present study was a mixed method study with a sequential exploratory approach. The research was conducted in 2023–2024 in Iran. The first phase data were collected from 20 healthcare professionals and were analyzed by conventional content analysis method. In the second phase, the validity and reliability of the instrument were evaluated by involving 300 healthcare professionals in the cardiac operating room. The moral intelligence of health care professionals in the cardiac operating room was defined as moral sensitivity combined with moral commitment and moral courage for the provision of quality care that respects the principles of medical ethics. After deducing the conceptual framework, the moral intelligence scale for healthcare professionals in the cardiac operating room was developed with three dimensions: “moral sensitivity,” “moral commitment,” and “moral courage.” 11 items were removed during testing to ensure content validity. Face validity was confirmed with impact scores > 1.5 for all items. A scale was developed through factor analysis with three factors that accounted for 73.04% of the observed variance. The instrument’s reliability using Cronbach’s alpha coefficient calculation was reported as 0.94 for the entire instrument. The testretest showed no statistically significant difference between the pre and post-test scores of moral intelligence (p = 0.51). The moral intelligence scale demonstrated acceptable psychometric properties. The moral intelligence scale for health care professionals in the cardiac operating room demonstrated acceptable psychometric properties. This instrument may serve to assess the moral intelligence of healthcare professionals and determine the need for educational interventions to reduce the ethical challenges and improve the moral intelligence of this healthcare.
- 24 February 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-10
Open AccessDesigning and psychometric assessment of the moral intelligence scale for healthcare professionals
The moral intelligence of healthcare professionals in the cardiac operating room is one of the most important aspects of professional competence. However, moral intelligence is an abstract and multidimensional concept that needs to be clarified and described based on organizational culture and environment. Therefore, there is a need to design a specific scale for measuring the moral intelligence of healthcare professionals in the cardiac operating room. This study aims to design and assess the psychometric properties of a moral intelligence scale for healthcare professionals in the cardiac operating room. The present study was a mixed method study with a sequential exploratory approach. The research was conducted in 2023–2024 in Iran. The first phase data were collected from 20 healthcare professionals and were analyzed by conventional content analysis method. In the second phase, the validity and reliability of the instrument were evaluated by involving 300 healthcare professionals in the cardiac operating room. The moral intelligence of health care professionals in the cardiac operating room was defined as moral sensitivity combined with moral commitment and moral courage for the provision of quality care that respects the principles of medical ethics. After deducing the conceptual framework, the moral intelligence scale for healthcare professionals in the cardiac operating room was developed with three dimensions: “moral sensitivity,” “moral commitment,” and “moral courage.” 11 items were removed during testing to ensure content validity. Face validity was confirmed with impact scores > 1.5 for all items. A scale was developed through factor analysis with three factors that accounted for 73.04% of the observed variance. The instrument’s reliability using Cronbach’s alpha coefficient calculation was reported as 0.94 for the entire instrument. The testretest showed no statistically significant difference between the pre and post-test scores of moral intelligence (p = 0.51). The moral intelligence scale demonstrated acceptable psychometric properties. The moral intelligence scale for health care professionals in the cardiac operating room demonstrated acceptable psychometric properties. This instrument may serve to assess the moral intelligence of healthcare professionals and determine the need for educational interventions to reduce the ethical challenges and improve the moral intelligence of this healthcare.
- Open Access
- 5 February 2024
- Published by Hindawi Limited in Cardiology Research and Practice
- Vol. 2024, 1-7
The Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
Objective. Primary percutaneous coronary intervention (PCI) is the best treatment for acute ST-elevation myocardial infarction (STEMI). Evidence is in favor of ticagrelor over clopidegrel in STEMI patients regarding the reduction of stent thrombosis risk during and after PCI. We compared initial thrombolysis in myocardial infarction (TIMI) flow in STEMI patients on ticagrelor vs. clopidogrel. Methods. This prospective cohort recruited 160 patients with acute STEMI, referred to the emergency department of Farshchian Heart Center, during March 2018–2019. Before angiography, the patients received clopidogrel (600 mg) or ticagrelor (180 mg) on top of aspirin. Initial TIMI flow was compared between the two groups as the primary outcome. A logistic regression was performed to calculate the predictors of initial TIMI flow. Analyses were performed using R, version 4.2.1. Results. In ticagrelor and clopidogrel groups, the mean ± standard deviation age of the patients was 59.46 ± 13.11 and 61.34 ± 11.08 years ( value = 0.33), respectively. In the ticagrelor and clopidogrel groups, initial TIMI flow grades were as follows: 0 : 50% and 71.2%, I: 26.2% and 16.2%, II: 12.5% and 10%, and III: 12.9% and 2.5%, respectively ( value = 0.005). Final TIMI flow grades were as follows: I: 26.2% and 16.2%, II: 7.5% and 13.8%, and III: 66.3% and 70%, respectively ( value = 0.41). Ticagrelor was associated with significantly higher initial TIMI flow grade compared to the clopidogrel group (adjusted odds ratio: 2.90 (95% CI: 1.51–5.72)). Conclusion. In STEMI patients who were candidates for primary PCI, ticagrelor administration led to a better initial TIMI flow grade compared to clopidogrel.- 5 February 2024
- Published by Hindawi Limited in Cardiology Research and Practice
- Vol. 2024, 1-7
Open AccessThe Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
Objective. Primary percutaneous coronary intervention (PCI) is the best treatment for acute ST-elevation myocardial infarction (STEMI). Evidence is in favor of ticagrelor over clopidegrel in STEMI patients regarding the reduction of stent thrombosis risk during and after PCI. We compared initial thrombolysis in myocardial infarction (TIMI) flow in STEMI patients on ticagrelor vs. clopidogrel. Methods. This prospective cohort recruited 160 patients with acute STEMI, referred to the emergency department of Farshchian Heart Center, during March 2018–2019. Before angiography, the patients received clopidogrel (600 mg) or ticagrelor (180 mg) on top of aspirin. Initial TIMI flow was compared between the two groups as the primary outcome. A logistic regression was performed to calculate the predictors of initial TIMI flow. Analyses were performed using R, version 4.2.1. Results. In ticagrelor and clopidogrel groups, the mean ± standard deviation age of the patients was 59.46 ± 13.11 and 61.34 ± 11.08 years ( value = 0.33), respectively. In the ticagrelor and clopidogrel groups, initial TIMI flow grades were as follows: 0 : 50% and 71.2%, I: 26.2% and 16.2%, II: 12.5% and 10%, and III: 12.9% and 2.5%, respectively ( value = 0.005). Final TIMI flow grades were as follows: I: 26.2% and 16.2%, II: 7.5% and 13.8%, and III: 66.3% and 70%, respectively ( value = 0.41). Ticagrelor was associated with significantly higher initial TIMI flow grade compared to the clopidogrel group (adjusted odds ratio: 2.90 (95% CI: 1.51–5.72)). Conclusion. In STEMI patients who were candidates for primary PCI, ticagrelor administration led to a better initial TIMI flow grade compared to clopidogrel. - 1 January 2023
- Vol. 13 (4) , 272-277
Multimodality imaging in diagnosis and management of patent ductus arteriosus in an adult: a case report
Patent ductus arteriosus (PDA) is a congenital heart disorder in which a vascular structure between the pulmonary artery and the aorta remains open. PDA normally closes shortly after birth. The treatment in adults is surgical or transcatheter closure. A 47-year-old woman presented to our hospital with a diagnosis of PDA and was treated with transcatheter closure. Although the recovery period of adult patients is long, this patient recovered completely after one day.
- 1 January 2023
- Vol. 13 (4) , 272-277
Multimodality imaging in diagnosis and management of patent ductus arteriosus in an adult: a case report
Patent ductus arteriosus (PDA) is a congenital heart disorder in which a vascular structure between the pulmonary artery and the aorta remains open. PDA normally closes shortly after birth. The treatment in adults is surgical or transcatheter closure. A 47-year-old woman presented to our hospital with a diagnosis of PDA and was treated with transcatheter closure. Although the recovery period of adult patients is long, this patient recovered completely after one day.